A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Elloumi, Houda Z ^a   Maharshak, Nitsan ^a   Rao, Kavitha N ^b   Kobayashi, Taku ^a   Ryu, Hyungjin S ^a   Mühlbauer, Marcus ^a   Li, Fengling ^a   Jobin, Christian ^a   Plevy, Scott E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11R VEET; 11R VIVIT; ANTIINFLAMMATORY AGENT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; MESSENGER RNA; PIROXICAM; PROTEIN INHIBITOR; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL MEMBRANE PERMEABILITY; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MEGADOSE; DRUG PROTEIN BINDING; EXPERIMENTAL MOUSE; LOW DRUG DOSE; MACROPHAGE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SUPERNATANT; ACTIVE TRANSPORT; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; FLUORESCENCE MICROSCOPY; GENETICS; INFLAMMATION; METABOLISM; METHODOLOGY; TRANSGENIC MOUSE;

MURINAE; MUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; BONE MARROW CELLS; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NFATC TRANSCRIPTION FACTORS; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TACROLIMUS;

EID: 84858978482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034172     Document Type: Article

References (67)

1. Han J, Ulevitch RJ, (2005) Limiting inflammatory responses during activation of innate immunity. Nat Immunol 6: 1198-1205.
2. Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, et al. (2001) Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 167: 2379-2387.
3. Honda K, Nakamura K, Matsui N, Takahashi M, Kitamura Y, et al. (2005) T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis. Inflamm Bowel Dis 11: 1044-1052.
4. Hong K, Chu A, Ludviksson BR, Berg EL, Ehrhardt RO, (1999) IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J Immunol 162: 7480-7491.
5. Tozawa K, Hanai H, Sugimoto K, Baba S, Sugimura H, et al. (2003) Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice. J Gastroenterol Hepatol 18: 578-587.
6. Brombacher F, Kastelein RA, Alber G, (2003) Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 24: 207-212.
7. Trinchieri G, (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146.
8. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B, (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
9. Trinchieri G, (1997) Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 9: 17-23.
10. Zhu C, Rao K, Xiong H, Gagnidze K, Li F, et al. (2003) Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J Biol Chem 278: 39372-39382.
11. Zhu C, Gagnidze K, Gemberling JH, Plevy SE, (2001) Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach. J Biol Chem 276: 18519-18528.
12. Plevy SE, Gemberling JH, Hsu S, Dorner AJ, Smale ST, (1997) Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol Cell Biol 17: 4572-4588.
13. Macian F, (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5: 472-484.
14. Granucci F, Zanoni I, (2009) The dendritic cell life cycle. Cell Cycle 8: 3816-3821.
15. Zanoni I, Ostuni R, Capuano G, Collini M, Caccia M, et al. (2009) CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 460: 264-268.
16. Sitara D, Aliprantis AO, (2010) Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev 233: 286-300.
17. Yarilina A, Xu K, Chen J, Ivashkiv LB, (2011) TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc Natl Acad Sci U S A 108: 1573-1578.
18. Ma W, Mishra S, Gee K, Mishra JP, Nandan D, et al. (2007) Cyclosporin A and FK506 inhibit IL-12p40 production through the calmodulin/calmodulin-dependent protein kinase-activated phosphoinositide 3-kinase in lipopolysaccharide-stimulated human monocytic cells. J Biol Chem 282: 13351-13362.
19. Kahan BD, (1989) Cyclosporine. N Engl J Med 321: 1725-1738.
20. Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Gritsch HA, et al. (1995) The superiority of tacrolimus in renal transplant recipients - the Pittsburgh experience. Clin Transpl pp. 199-205.
21. Testa G, Klintmalm GB, (1997) Cyclosporine and tacrolimus: the mainstay of immunosuppressive therapy for solid organ transplantation. Clin Liver Dis 1: 417-437, x.
22. Kitahara K, Kawai S, (2007) Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr Opin Rheumatol 19: 238-245.
23. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, et al. (1999) Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 285: 2129-2133.
24. Noguchi H, Matsushita M, Okitsu T, Moriwaki A, Tomizawa K, et al. (2004) A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 10: 305-309.
25. Kuriyama M, Matsushita M, Tateishi A, Moriwaki A, Tomizawa K, et al. (2006) A cell-permeable NFAT inhibitor peptide prevents pressure-overload cardiac hypertrophy. Chem Biol Drug Des 67: 238-243.
26. Karrasch T, Kim JS, Muhlbauer M, Magness ST, Jobin C, (2007) Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol 178: 6522-6532.
27. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, et al. (2002) Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 123: 1527-1542.
28. Xiong H, Zhu C, Li F, Hegazi R, He K, et al. (2004) Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. J Biol Chem 279: 10776-10783.
29. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, et al. (2005) Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med 202: 1703-1713.
30. Rogers AB, Houghton J, (2009) Helicobacter-based mouse models of digestive system carcinogenesis. Methods Mol Biol 511: 267-295.
31. Du S, Hiramatsu N, Hayakawa K, Kasai A, Okamura M, et al. (2009) Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol 182: 7201-7211.
32. Minematsu H, Shin MJ, Celil Aydemir AB, Seo SW, Kim DW, et al. (2007) Orthopedic implant particle-induced tumor necrosis factor-alpha production in macrophage-monocyte lineage cells is mediated by nuclear factor of activated T cells. Ann N Y Acad Sci 1117: 143-150.
33. Tsai EY, Jain J, Pesavento PA, Rao A, Goldfeld AE, (1996) Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol 16: 459-467.
34. Tsai EY, Yie J, Thanos D, Goldfeld AE, (1996) Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol 16: 5232-5244.
35. Xiong H, Zhu C, Li H, Chen F, Mayer L, et al. (2003) Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J Biol Chem 278: 2271-2277.
36. Hamalainen M, Lahti A, Moilanen E, (2002) Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines. Eur J Pharmacol 448: 239-244.
37. Hamalainen M, Korhonen R, Moilanen E, (2009) Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA. Int Immunopharmacol 9: 159-167.
38. Xie QW, Whisnant R, Nathan C, (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177: 1779-1784.
39. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
40. Aste-Amezaga M, Ma X, Sartori A, Trinchieri G, (1998) Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 160: 5936-5944.
41. Shen Z, Chen L, Hao F, Wu J, (2009) Transcriptional regulation of Foxp3 gene: multiple signal pathways on the road. Med Res Rev 29: 742-766.
42. Winslow MM, Gallo EM, Neilson JR, Crabtree GR, (2006) The calcineurin phosphatase complex modulates immunogenic B cell responses. Immunity 24: 141-152.
43. Monticelli S, Solymar DC, Rao A, (2004) Role of NFAT proteins in IL13 gene transcription in mast cells. J Biol Chem 279: 36210-36218.
44. Seminario MC, Guo J, Bochner BS, Beck LA, Georas SN, (2001) Human eosinophils constitutively express nuclear factor of activated T cells p and c. J Allergy Clin Immunol 107: 143-152.
45. Schroeder JT, Miura K, Kim HH, Sin A, Cianferoni A, et al. (2002) Selective expression of nuclear factor of activated T cells 2/c1 in human basophils: evidence for involvement in IgE-mediated IL-4 generation. J Allergy Clin Immunol 109: 507-513.
46. Aramburu J, Azzoni L, Rao A, Perussia B, (1995) Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding. J Exp Med 182: 801-810.
47. Hirotani H, Tuohy NA, Woo JT, Stern PH, Clipstone NA, (2004) The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 279: 13984-13992.
48. Conboy IM, Manoli D, Mhaiskar V, Jones PP, (1999) Calcineurin and vacuolar-type H+-ATPase modulate macrophage effector functions. Proc Natl Acad Sci U S A 96: 6324-6329.
49. Kim Y, Moon JS, Lee KS, Park SY, Cheong J, et al. (2004) Ca2+/calmodulin-dependent protein phosphatase calcineurin mediates the expression of iNOS through IKK and NF-kappaB activity in LPS-stimulated mouse peritoneal macrophages and RAW 264.7 cells. Biochem Biophys Res Commun 314: 695-703.
50. Miskin JE, Abrams CC, Dixon LK, (2000) African swine fever virus protein A238L interacts with the cellular phosphatase calcineurin via a binding domain similar to that of NFAT. J Virol 74: 9412-9420.
51. Jeffrey KL, Brummer T, Rolph MS, Liu SM, Callejas NA, et al. (2006) Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1. Nat Immunol 7: 274-283.
52. Tsytsykova AV, Rajsbaum R, Falvo JV, Ligeiro F, Neely SR, et al. (2007) Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers. Proc Natl Acad Sci U S A 104: 16850-16855.
53. Falvo JV, Uglialoro AM, Brinkman BM, Merika M, Parekh BS, et al. (2000) Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol 20: 2239-2247.
54. Nagamoto-Combs K, Combs CK, (2010) Microglial phenotype is regulated by activity of the transcription factor, NFAT (nuclear factor of activated T cells). J Neurosci 30: 9641-9646.
55. Peng SL, Gerth AJ, Ranger AM, Glimcher LH, (2001) NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14: 13-20.
56. Hodge MR, Ranger AM, Charles de la Brousse F, Hoey T, Grusby MJ, et al. (1996) Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4: 397-405.
57. Weigmann B, Lehr HA, Yancopoulos G, Valenzuela D, Murphy A, et al. (2008) The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. J Exp Med 205: 2099-2110.
58. Porter CM, Clipstone NA, (2002) Sustained NFAT signaling promotes a Th1-like pattern of gene expression in primary murine CD4+ T cells. J Immunol 168: 4936-4945.
59. Hermann-Kleiter N, Baier G, (2010) NFAT pulls the strings during CD4+ T helper cell effector functions. Blood 115: 2989-2997.
60. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, et al. (2008) Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9: 194-202.
61. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, et al. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
62. Jennings C, Kusler B, Jones PP, (2009) Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo. Innate Immun 15: 109-120.
63. Dave SH, Tilstra JS, Matsuoka K, Li F, Karrasch T, et al. (2007) Amelioration of chronic murine colitis by peptide-mediated transduction of the IkappaB kinase inhibitor NEMO binding domain peptide. J Immunol 179: 7852-7859.
64. Choi JM, Shin JH, Sohn MH, Harding MJ, Park JH, et al. (2010) Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc Natl Acad Sci U S A 107: 18575-18580.
65. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, et al. (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815.
66. Bechstein WO, (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13: 313-326.
67. Olyaei AJ, de Mattos AM, Bennett WM, (2001) Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care 7: 384-389.